Related Experiment Videos
Effect of bleomycin on deoxynucleotide-polymerizing enzymes from human cells
Cancer Research
|May 1, 1976
Summary
Bleomycin inhibits DNA polymerases alpha and beta by interacting with DNA templates, a process dependent on thiol reagents. This interaction is reversed by adding more DNA, suggesting a role in bleomycin's antitumor activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Bleomycin is an anticancer drug known to induce DNA damage.
- The precise mechanism by which bleomycin affects DNA synthesis enzymes is not fully understood.
Purpose of the Study:
- To investigate the effect of bleomycin on specific DNA polymerases.
- To elucidate the mechanism of bleomycin-induced inhibition of DNA polymerases.
Main Methods:
- Assaying DNA polymerases alpha, beta, gamma, and terminal deoxynucleotidyl transferase activity.
- Kinetic analysis (Km, Vmax) of enzyme inhibition.
- Investigating the role of dithiothreitol and DNA in bleomycin's inhibitory action.
Main Results:
- Bleomycin inhibited DNA polymerases alpha and beta, but not gamma or terminal deoxynucleotidyl transferase.
- Inhibition involved an increased Km for template DNA and reduced Vmax when dTTP was varied.
- Bleomycin's inhibitory activity was dependent on thiol reagents and reversed by excess template DNA.
Conclusions:
- Bleomycin inhibits DNA polymerases alpha and beta via a thiol reagent-dependent interaction with the DNA template.
- The antitumor efficacy of bleomycin may be modulated by cellular sulfhydryl compound concentrations and DNA accessibility.